share_log

花旗：予微创医疗(00853)“买入”评级 目标价降至21港元

Citigroup: Initiate coverage on Microport (00853) with a "buy" rating, target price lowered to HKD 21.

Zhitong Finance ·  Jun 14 15:30

Citi expects Microport (00853) to increase its earnings per share by 59.4%/43% in 2024/2025.

According to the latest guidance from the management of Microport (00853) and recent sales trends, Citigroup adjusted its earnings per share forecast and expects a 59.4% growth in earnings per share in 2024 and a 43% growth in earnings per share in 2025, reflecting the company's strict cost control trend. The target price has been lowered from HKD 25 to HKD 21 to reflect the downgrade of the valuation of the heart valve business, and the rating is set as "buy".

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment